Edition:
United States

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

87.52USD
18 May 2018
Change (% chg)

$-0.03 (-0.03%)
Prev Close
$87.55
Open
$87.96
Day's High
$88.45
Day's Low
$87.01
Volume
115,354
Avg. Vol
146,317
52-wk High
$94.13
52-wk Low
$40.49

Chart for

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximatel... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $5,143.08
Shares Outstanding(Mil.): 58.74
Dividend: --
Yield (%): --

Financials

  PODD.OQ Industry Sector
P/E (TTM): -- 39.22 32.53
EPS (TTM): -0.40 -- --
ROI: -4.01 14.34 12.63
ROE: -19.75 17.22 14.50

BRIEF-Insulet Reports Q1 Loss Per Share $0.11

* INSULET REPORTS FIRST QUARTER 2018 REVENUE OF $123.6 MILLION, UP 21% YEAR-OVER-YEAR, AND GROSS MARGIN OF 61.4%, UP 300 BASIS POINTS, EXCEEDING EXPECTATIONS

May 03 2018

BRIEF-Insulet Establishes Two Significant Commercial Partnerships To Support Its European Expansion

* INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL PARTNERSHIPS TO SUPPORT ITS EUROPEAN EXPANSION

May 01 2018

BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016

* INSULET CORP SAYS CEO PATRICK J. SULLIVAN'S 2017 TOTAL COMPENSATION WAS $8.2 MLN VS $6 MLN IN 2016 – SEC FILING‍​‍​ Source text: (https://bit.ly/2EsXkmY) Further company coverage:

Apr 06 2018

UPDATE 1-Ypsomed says 2019/20 profit to fall, followed by rebound

ZURICH, March 7 Swiss insulin pump maker Ypsomed , responding to a report on Wednesday that had sent its shares tumbling, said 2019/20 profit will likely fall amid market uncertainties but will then rebound as it expands with new subsidiaries.

Mar 07 2018

BRIEF-Insulet Corp Posts Q4 Loss Per Share $0.12

* INSULET REPORTS FOURTH QUARTER REVENUE OF $130.5 MILLION, UP 26%, AND GROSS MARGIN UP 210 BASIS POINTS, EXCEEDING EXPECTATIONS

Feb 21 2018

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT

Jan 09 2018

Competitors

Earnings vs. Estimates